peanut_shaker
Active member
If both your clinician and doctor are aligned on GLP-1 as the recommendation, that's actually a strong position to start from - having the medical team on board means you're not navigating the justification argument while also managing side effects. The nearly obese classification with clinical backing is exactly the profile these medications were designed for.